Short answer
Definitive Healthcare Corp. (DH) filed an 8-K current report with the SEC on August 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Filing provides no earnings metrics or results commentary; substantive 2.02 information likely resides in an incorporated exhibit.
Definitive Healthcare Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Filing provides no earnings metrics or results commentary; substantive 2.02 information likely resides in an incorporated exhibit
- CFO Casey Heller signed the report on August 10, 2026
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $55.2M, down 9% YoY, signaling continued top-line pressure despite customer win-backs and expansion activity
- Adjusted EBITDA $14.6M, margin 26%, down from $18.7M and 31% YoY, indicating weaker operating leverage
- Operating cash flow $11.5M and unlevered free cash flow $11.6M, supporting liquidity while revenue declines
- Q3 revenue guidance $54.0–$55.0M and full-year guidance $220.0–$222.0M, implying limited near-term growth visibility
- Turbo AI platform launch and improving net dollar retention provide potential recovery catalysts, but execution and data-quality risks remain
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Definitive Healthcare Corp. 8-K filings
Get the next DH 8-K as it lands
Follow DH for push alerts, or ask the research agent what this filing means.